October 13, 2006

BATTELLE SPONSORS PREMIER MEDICAL TECHNOLOGY CONFERENCE TO ADVANCE MEDICAL DEVICE INNOVATION

Columbus, OH--Battelle is investing in emerging medical technology as an underwriting sponsor for Medtech Insight's Investment in Innovation (In³) Conference Series.

In³ creates a unique forum for small medical device companies to interface with venture capital firms and industry-leading medical device companies. Last month, In³ Europe was hosted in Brussels, Belgium and focused on collaboration among U.S. and European medical device innovators, investors, and companies.

In³ East is October 18-20, in Boston, Massachusetts, and features 50 emerging medical device companies representing technologies across a wide range of clinical market segments.

Medtech Insight, a division of Windhover Information, Inc., provides business information and intelligence on new trends, technologies, and companies in the medical device, diagnostics, and biotech marketplace. More than 700 innovative early-stage companies have participated in In³ conferences since the first meeting in 2001. Battelle Medical Device Solutions was a founding sponsor and has consistently supported this initiative.

"Battelle continues to be a leader in outsourced research and development for the medical device industry and we're very proud to have them as a founding and longtime alumni sponsor of the In³ conference series," says David Cassak, Managing Partner, Windhover Information. "The In³ franchise has grown tremendously over the past five years thanks to the support of world class organizations like Battelle."

Battelle Medical Device Solutions delivers a comprehensive set of development services to medical device, biotechnology, and pharmaceutical companies. Providing services in applied research, device development, clinical research, and sustaining engineering, Medical Device Solutions is experienced with a wide range of Class II and Class III medical devices from diagnostic instruments to drug delivery systems.

Battelle is a global leader in science and technology. Headquartered in Columbus, Ohio, it develops and commercializes technology and manages laboratories for customers. Battelle, with the national labs it manages or co-manages, oversees 20,000 staff members and conducts $3.4 billion in annual research and development. Battelle innovations have included the development of the office copier machine (Xerox); pioneering work on compact disc technology; fiber optics for telecommunications; new medical products to fight diabetes, cancer and heart disease; breakthroughs in environmental waste treatment; homeland security technologies; and advancements in transportation safety and security.

For more information, contact Todd Tomba, at tombat@battelle.org or (614) 424-6309.

For more information about Medtech Insight, visit www.medtechinsight.com.